A respiratory tract infection is an infection of the lungs, trachea, throat, and nose. Before the COVID-19 pandemic, Influenza and RSV are the two leading causes of respiratory diseases. However, they often present with similar clinical symptoms, making it difficult for healthcare providers to identify the two infections and deliver targeted therapies timely. Therefore, rapid molecular testing, which provides accurate and reliable detection of Flu and RSV on the spot, has become essential to improve patient management.
VitaPCR™ – Accurate diagnostics, whenever and wherever you need it.
Combining a simplified 1 minute hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design without the need for extra equipment like refrigeration, and a proprietary RT-PCR technology allowing fast and accurate diagnostics; VitaPCR™ allows the detection of Influenza virus & RSV in 20 minutes from sample to results, at the Point-of-Care.
VitaPCR™ empowers practitioners with the right information at the right time to make the right decision and provide the right course of treatment to the patients.
Usability
- Minimal Training Required
- No additional equipment needed
- Room Temperature Storage
Performance
- High Accuracy
- Short Turnaround Time
- Intuitive result interpretation with Ct value & fluorescence curve
Diagnostic Procedure in 4 Steps
1. Collect: Collect sample
2. Lyse: Lyse the sample thoroughly for 15 times
3. Transfer: Transfer the sample
4. Start Run: Results reported in 20 minutes